Search jobs 07-May-2021 Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future
Transaction values Science 37 at an enterprise value of approximately $1.05 billion at closing
Positions Science 37 with a balance sheet of up to $250 million to fund its decentralized trial technology platform, extend into new adjacencies, and power the next generation in clinical research
$80 million via LifeSci Acquisition II Corp., a special purpose acquisition company with no public warrants
$200 million via fully committed and upsized PIPE from leading institutional and strategic investors including Redmile Group; funds and accounts managed by BlackRock; Casdin Capital; dRx Capital (Novartis Pharma AG); LifeSci Venture Partners; Lux Capital; Mubadala Capital, the asset management arm of Mubadala Investment Company; Perceptive Advisors; PPD; Pura Vida Investments;
ಬ್ರೆಜಿಲ್: 24 ಗಂಟೆಯಲ್ಲಿ 2,914 ಹೊಸ ಕೊರೋನಾ ಸಾವು ಪ್ರಕರಣ ದಾಖಲು
kannadaprabha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kannadaprabha.com Daily Mail and Mail on Sunday newspapers.
ಬ್ರೆಜಿಲ್: 24 ಗಂಟೆಯಲ್ಲಿ 2914 ಹೊಸ ಕೊರೋನಾ ಸಾವು ಪ್ರಕರಣ ವರದಿ
kannadaprabha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kannadaprabha.com Daily Mail and Mail on Sunday newspapers.
Stem cell therapy can repair brain damage and improve memory function in mice
A one-time injection of an experimental stem cell therapy can repair brain damage and improve memory function in mice with conditions that replicate human strokes and dementia, a new UCLA study finds.
Dementia can arise from multiple conditions, and it is characterized by an array of symptoms including problems with memory, attention, communication and physical coordination. The two most common causes of dementia are Alzheimer s disease and white matter strokes -; small strokes that accumulate in the connecting areas of the brain. It s a vicious cycle: The two leading causes of dementia are almost always seen together and each one accelerates the other, said Dr. S. Thomas Carmichael, senior author of the study and interim director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.